Janssen COVID-19 Vaccine: Package Insert and Label Information (Page 5 of 5)
PRINCIPAL DISPLAY PANEL — 10 Vial Carton
OPEN
HERE
NDC 59676-580-15
No Preservative
10 Multi-dose Vials
Each vial contains 5 doses of 0.5 mL
Janssen COVID-19 Vaccine
SUSPENSION FOR INTRAMUSCULAR INJECTION
For use under Emergency Use Authorization
Attention: After first use, hold at 2°C to 8°C
(36°F to 46°F). Discard after 6 hours.Do not freeze.
janssen
JANSSEN COVID-19 VACCINE ad26.cov2.s injection, suspension | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Labeler — Janssen Products, LP (804684207) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Janssen | 415960780 | API MANUFACTURE (59676-580) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Jannsen Biologics B.V. | 409612918 | API MANUFACTURE (59676-580) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Grand River Aseptic Manufacturing, Inc. | 005593490 | MANUFACTURE (59676-580), ANALYSIS (59676-580) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Emergent Manufacturing Operations Baltimore LLC | 968316831 | MANUFACTURE (59676-580), ANALYSIS (59676-580) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Packaging Coordinators, LLC | 078525133 | PACK (59676-580), LABEL (59676-580) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Catalent Indiana, LLC | 172209277 | MANUFACTURE (59676-580), PACK (59676-580), ANALYSIS (59676-580) |
Revised: 04/2021 Janssen Products, LP
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.
https://druginserts.com/lib/other/meds/janssen-covid-19-vaccine/page/5/